Lin YangAssociate Director of Discovery at Alloy TherapeuticsSpeaker
Profile
Lin Yang is the Associate Director of Discovery at Alloy Therapeutics, where she leads multidisciplinary efforts to identify and advance novel therapeutic candidates. With deep expertise in antibody engineering and directed evolution, Lin oversees early-stage discovery programs from target validation through lead optimization. Her team leverages multiple display platforms to discover highly functional protein binders that align closely with each program’s target product profile. Before joining Alloy, Lin was a postdoctoral fellow in Dr. Sai Reddy’s group at ETH Zürich, where she led research integrating AI/ML with directed evolution to accelerate antibody discovery. Lin earned her PhD in Chemical and Biomolecular Engineering in Dr. Jamie Spangler’s lab at Johns Hopkins University, where her research focused on antibody engineering.
Agenda Sessions
From Difficult Targets to Drug Candidates: Alloy’s Integrated Platform for High- Affinity, Functional Antibody Discovery
, 7:30amView Session
